Immunology in clinic review series; focus on autoinflammatory diseases: Role of inflammasomes in autoinflammatory syndromes

Clinical and Experimental Immunology

Volumn 167, Issue 3, 2012, Pages 382-390

  Ozkurede, V U ^a   Franchi, L ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

IL 1 ; Inflammasome; Inflammation; Innate immunity

Indexed keywords

CRYOPYRIN; INFLAMMASOME; INTERLEUKIN 1BETA;

AUTOINFLAMMATORY DISEASE; CINCA SYNDROME; CYTOKINE PRODUCTION; FAMILIAL MEDITERRANEAN FEVER; HUMAN; MOLECULAR MECHANICS; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

CARRIER PROTEINS; CRYOPYRIN-ASSOCIATED PERIODIC SYNDROMES; CYTOSKELETAL PROTEINS; FAMILIAL MEDITERRANEAN FEVER; HEREDITARY AUTOINFLAMMATORY DISEASES; HUMANS; IMMUNITY, INNATE; INFLAMMASOMES; INTERLEUKIN-1BETA; MODELS, IMMUNOLOGICAL; MUTATION; SIGNAL TRANSDUCTION; SYNDROME;

EID: 84856394478     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2011.04535.x     Document Type: Review

References (87)

1. Masters SL, Simon A, Aksentijevich I, Kastner DL. Horror autoinflammaticus: the molecular pathophysiology of autoinflammatory disease (*). Annu Rev Immunol 2009; 27:621-68.
2. Hoffman HM, Simon A. Recurrent febrile syndromes: what a rheumatologist needs to know. Nat Rev Rheumatol 2009; 5:249-56.
3. Kastner DL, Aksentijevich I, Goldbach-Mansky R. Autoinflammatory disease reloaded: a clinical perspective. Cell 2010; 140:784-90.
4. Goldbach-Mansky R. Immunology in clinic review series; focus on autoinflammatory diseases: update on monogenic autoinflammatory diseases: the role of interleukin (IL)-1 and an emerging role for cytokines beyond IL-1. Clin Exp Immun 2012; 167:391-404.
5. Dinarello CA. Biologic basis for interleukin-1 in disease. Blood 1996; 87:2095-147.
6. Bochner BS, Luscinskas FW, Gimbrone MA etal. Adhesion of human basophils, eosinophils, and neutrophils to interleukin 1-activated human vascular endothelial cells: contributions of endothelial cell adhesion molecules. J Exp Med 1991; 173:1553-7.
7. Russo HM, Wickenheiser KJ, Luo W etal. P-selectin glycoprotein ligand-1 regulates adhesive properties of the endothelium and leukocyte trafficking into adipose tissue. Circ Res 2010; 107:388-97.
8. Dinarello CA. A clinical perspective of IL-1beta as the gatekeeper of inflammation. Eur J Immunol 2011; 41:1203-17.
9. van de Veerdonk FL, Netea MG, Dinarello CA, Joosten LA. Inflammasome activation and IL-1beta and IL-18 processing during infection. Trends Immunol 2011; 32:110-16.
10. Franchi L, McDonald C, Kanneganti TD, Amer A, Nunez G. Nucleotide-binding oligomerization domain-like receptors: intracellular pattern recognition molecules for pathogen detection and host defense. J Immunol 2006; 177:3507-13.
11. Franchi L, Park JH, Shaw MH etal. Intracellular NOD-like receptors in innate immunity, infection and disease. Cell Microbiol 2008; 10:1-8.
12. Embry CA, Franchi L, Nunez G, Mitchell TC. Mechanism of impaired NLRP3 inflammasome priming by monophosphoryl lipid A. Sci Signal 2011; 4:ra28.
13. Marina-Garcia N, Franchi L, Kim YG etal. Clathrin- and dynamin-dependent endocytic pathway regulates muramyl dipeptide internalization and NOD2 activation. J Immunol 2009; 182:4321-7.
14. Samavati L, Rastogi R, Du W, Huttemann M, Fite A, Franchi L. STAT3 tyrosine phosphorylation is critical for interleukin 1 beta and interleukin-6 production in response to lipopolysaccharide and live bacteria. Mol Immunol 2009; 46:1867-77.
15. Franchi L, Eigenbrod T, Munoz-Planillo R, Nunez G. The inflammasome: a caspase-1-activation platform that regulates immune responses and disease pathogenesis. Nat Immunol 2009; 10:241-7.
16. Martinon F, Tschopp J. Inflammatory caspases and inflammasomes: master switches of inflammation. Cell Death Differ 2007; 14:10-22.
17. Qu Y, Ramachandra L, Mohr S etal. P2X7 receptor-stimulated secretion of MHC class II-containing exosomes requires the ASC/NLRP3 inflammasome but is independent of caspase-1. J Immunol 2009; 182:5052-62.
18. MacKenzie A, Wilson HL, Kiss-Toth E, Dower SK, North RA, Surprenant A. Rapid secretion of interleukin-1beta by microvesicle shedding. Immunity 2001; 15:825-35.
19. Andrei C, Dazzi C, Lotti L, Torrisi MR, Chimini G, Rubartelli A. The secretory route of the leaderless protein interleukin 1beta involves exocytosis of endolysosome-related vesicles. Mol Biol Cell 1999; 10:1463-75.
20. Brough D, Rothwell NJ. Caspase-1-dependent processing of pro-interleukin-1beta is cytosolic and precedes cell death. J Cell Sci 2007; 120:772-81.
21. Horai R, Saijo S, Tanioka H etal. Development of chronic inflammatory arthropathy resembling rheumatoid arthritis in interleukin 1 receptor antagonist-deficient mice. J Exp Med 2000; 191:313-20.
22. Nicklin MJ, Hughes DE, Barton JL, Ure JM, Duff GW. Arterial inflammation in mice lacking the interleukin 1 receptor antagonist gene. J Exp Med 2000; 191:303-12.
23. Aksentijevich I, Masters SL, Ferguson PJ etal. An autoinflammatory disease with deficiency of the interleukin-1-receptor antagonist. N Engl J Med 2009; 360:2426-37.
24. Reddy VS, Harskamp RE, van Ginkel MW etal. Interleukin-18 stimulates fibronectin expression in primary human cardiac fibroblasts via PI3K-Akt-dependent NF-kappaB activation. J Cell Physiol 2008; 215:697-707.
25. Bauernfeind F, Ablasser A, Bartok E etal. Inflammasomes: current understanding and open questions. Cell Mol Life Sci 2011; 68:765-83.
26. Martinon F, Burns K, Tschopp J. The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Mol Cell 2002; 10:417-26.
27. Mankan AK, Kubarenko A, Hornung V. Immunology in the clinic review series; focus on autoinflammatory diseases: inflammasomes: mechanisms of activation. Clin Exp Immun 2012; 167:369-81.
28. Faustin B, Lartigue L, Bruey JM etal. Reconstituted NALP1 inflammasome reveals two-step mechanism of caspase-1 activation. Mol Cell 2007; 25:713-24.
29. Franchi L, Amer A, Body-Malapel M etal. Cytosolic flagellin requires Ipaf for activation of caspase-1 and interleukin 1beta in salmonella-infected macrophages. Nat Immunol 2006; 7:576-82.
30. Miao EA, Alpuche-Aranda CM, Dors M etal. Cytoplasmic flagellin activates caspase-1 and secretion of interleukin 1beta via Ipaf. Nat Immunol 2006; 7:569-75.
31. Franchi L, Stoolman J, Kanneganti TD, Verma A, Ramphal R, Nunez G. Critical role for Ipaf in Pseudomonas aeruginosa-induced caspase-1 activation. Eur J Immunol 2007; 37:3030-9.
32. Amer A, Franchi L, Kanneganti TD etal. Regulation of Legionella phagosome maturation and infection through flagellin and host Ipaf. J Biol Chem 2006; 281:35217-23.
33. Franchi L, Warner N, Viani K, Nunez G. Function of Nod-like receptors in microbial recognition and host defense. Immunol Rev 2009; 227:106-28.
34. Kofoed EM, Vance RE. Innate immune recognition of bacterial ligands by NAIPs determines inflammasome specificity. Nature 2011; 477:592-5.
35. Suzuki T, Franchi L, Toma C etal. Differential regulation of caspase-1 activation, pyroptosis, and autophagy via Ipaf and ASC in Shigella-infected macrophages. PLoS Pathog 2007; 3:e111.
36. Miao EA, Mao DP, Yudkovsky N etal. Innate immune detection of the type III secretion apparatus through the NLRC4 inflammasome. Proc Natl Acad Sci USA 2010; 107:3076-80.
37. Alnemri ES. Sensing cytoplasmic danger signals by the inflammasome. J Clin Immunol 2010; 30:512-19.
38. Hornung V, Latz E. Intracellular DNA recognition. Nat Rev Immunol 2010; 10:123-30.
39. Franchi L, Kanneganti TD, Dubyak GR, Nunez G. Differential requirement of P2X7 receptor and intracellular K+ for caspase-1 activation induced by intracellular and extracellular bacteria. J Biol Chem 2007; 282:18810-18.
40. Kim S, Bauernfeind F, Ablasser A etal. Listeria monocytogenes is sensed by the NLRP3 and AIM2 Inflammasome. Eur J Immunol 2010; 40:1545-51.
41. Mariathasan S, Weiss DS, Newton K etal. Cryopyrin activates the inflammasome in response to toxins and ATP. Nature 2006; 440:228-32.
42. Rathinam VA, Jiang Z, Waggoner SN etal. The AIM2 inflammasome is essential for host defense against cytosolic bacteria and DNA viruses. Nat Immunol 2010; 11:395-402.
43. Sauer JD, Witte CE, Zemansky J, Hanson B, Lauer P, Portnoy DA. Listeria monocytogenes triggers AIM2-mediated pyroptosis upon infrequent bacteriolysis in the macrophage cytosol. Cell Host Microbe 2010; 7:412-19.
44. Tsuchiya K, Hara H, Kawamura I etal. Involvement of absent in melanoma 2 in inflammasome activation in macrophages infected with Listeria monocytogenes. J Immunol 2010; 185:1186-95.
45. Mayer-Barber KD, Barber DL, Shenderov K etal. Caspase-1 independent IL-1beta production is critical for host resistance to mycobacterium tuberculosis and does not require TLR signaling in vivo. J Immunol 2010; 184:3326-30.
46. Dinarello CA. Interleukin-1 in the pathogenesis and treatment of inflammatory diseases. Blood 2011; 117:3720-32.
47. Cassel SL, Sutterwala FS. Sterile inflammatory responses mediated by the NLRP3 inflammasome. Eur J Immunol 2010; 40:607-11.
48. Franchi L, Munoz-Planillo R, Reimer T, Eigenbrod T, Nunez G. Inflammasomes as microbial sensors. Eur J Immunol 2010; 40:611-15.
49. Kahlenberg JM, Lundberg KC, Kertesy SB, Qu Y, Dubyak GR. Potentiation of caspase-1 activation by the P2X7 receptor is dependent on TLR signals and requires NF-kappaB-driven protein synthesis. J Immunol 2005; 175:7611-22.
50. Bauernfeind FG, Horvath G, Stutz A etal. Cutting edge: NF-kappaB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression. J Immunol 2009; 183:787-91.
51. Franchi L, Eigenbrod T, Nunez G. Cutting edge: TNF-{alpha} mediates sensitization to ATP and silica via the NLRP3 inflammasome in the absence of microbial stimulation. J Immunol 2009; 183:792-6.
52. Netea MG, Nold-Petry CA, Nold MF etal. Differential requirement for the activation of the inflammasome for processing and release of IL-1beta in monocytes and macrophages. Blood 2009; 113:2324-35.
53. Piccini A, Carta S, Tassi S, Lasiglie D, Fossati G, Rubartelli A. ATP is released by monocytes stimulated with pathogen-sensing receptor ligands and induces IL-1beta and IL-18 secretion in an autocrine way. Proc Natl Acad Sci USA 2008; 105:8067-72.
54. Harder J, Franchi L, Munoz-Planillo R, Park JH, Reimer T, Nunez G. Activation of the Nlrp3 inflammasome by Streptococcus pyogenes requires streptolysin O and NF-kappaB activation but proceeds independently of TLR signaling and P2X7 receptor. J Immunol 2009; 183:5823-9.
55. Munoz-Planillo R, Franchi L, Miller LS, Nunez G. A critical role for hemolysins and bacterial lipoproteins in Staphylococcus aureus-induced activation of the Nlrp3 inflammasome. J Immunol 2009; 183:3942-8.
56. Kanneganti TD, Ozoren N, Body-Malapel M etal. Bacterial RNA and small antiviral compounds activate caspase-1 through cryopyrin/Nalp3. Nature 2006; 440:233-6.
57. Rathinam VA, Fitzgerald KA. Inflammasomes and anti-viral immunity. J Clin Immunol 2010; 30:632-7.
58. Joly S, Sutterwala FS. Fungal pathogen recognition by the NLRP3 inflammasome. Virulence 2010; 1:276-80.
59. Ferrari D, Pizzirani C, Adinolfi E etal. The P2X7 receptor: a key player in IL-1 processing and release. J Immunol 2006; 176:3877-83.
60. Martinon F, Petrilli V, Mayor A, Tardivel A, Tschopp J. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 2006; 440:237-41.
61. Duewell P, Kono H, Rayner KJ etal. NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature 2010; 464:1357-61.
62. Masters SL, Dunne A, Subramanian SL etal. Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1beta in type 2 diabetes. Nat Immunol 2010; 11:897-904.
63. Hornung V, Bauernfeind F, Halle A etal. Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization. Nat Immunol 2008; 9:847-56.
64. Franchi L, Chen G, Marina-Garcia N etal. Calcium-independent phospholipase A2beta is dispensable for inflammasome activation and its inhibition by bromoenol lactone. J Innate Immun 2009; 1:607-17.
65. Zhou R, Tardivel A, Thorens B, Choi I, Tschopp J. Thioredoxin-interacting protein links oxidative stress to inflammasome activation. Nat Immunol 2010; 11:136-40.
66. Meissner F, Molawi K, Zychlinsky A. Superoxide dismutase 1 regulates caspase-1 and endotoxic shock. Nat Immunol 2008; 9:866-72.
67. Bauernfeind F, Bartok E, Rieger A, Franchi L, Nunez G, Hornung V. Cutting edge: reactive oxygen species inhibitors block priming, but not activation, of the NLRP3 inflammasome. J Immunol 2011; 187:613-17.
68. van de Veerdonk FL, Smeekens SP, Joosten LA etal. Reactive oxygen species-independent activation of the IL-1beta inflammasome in cells from patients with chronic granulomatous disease. Proc Natl Acad Sci USA 2010; 107:3030-3.
69. Feldmann J, Prieur AM, Quartier P etal. Chronic infantile neurological cutaneous and articular syndrome is caused by mutations in CIAS1, a gene highly expressed in polymorphonuclear cells and chondrocytes. Am J Hum Genet 2002; 71:198-203.
70. Hoffman HM, Mueller JL, Broide DH, Wanderer AA, Kolodner RD. Mutation of a new gene encoding a putative pyrin-like protein causes familial cold autoinflammatory syndrome and Muckle-Wells syndrome. Nat Genet 2001; 29:301-5.
71. Agostini L, Martinon F, Burns K, McDermott MF, Hawkins PN, Tschopp J. NALP3 forms an IL-1beta-processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder. Immunity 2004; 20:319-25.
72. Dowds TA, Masumoto J, Zhu L, Inohara N, Nunez G. Cryopyrin-induced interleukin 1beta secretion in monocytic cells: enhanced activity of disease-associated mutants and requirement for ASC. J Biol Chem 2004; 279:21924-8.
73. Duncan JA, Bergstralh DT, Wang Y etal. Cryopyrin/NALP3 binds ATP/dATP, is an ATPase, and requires ATP binding to mediate inflammatory signaling. Proc Natl Acad Sci USA 2007; 104:8041-6.
74. Brydges SD, Mueller JL, McGeough MD etal. Inflammasome-mediated disease animal models reveal roles for innate but not adaptive immunity. Immunity 2009; 30:875-87.
75. Meng G, Zhang F, Fuss I, Kitani A, Strober W. A mutation in the Nlrp3 gene causing inflammasome hyperactivation potentiates Th17 cell-dominant immune responses. Immunity 2009; 30:860-74.
76. Hoffman HM, Throne ML, Amar NJ etal. Efficacy and safety of rilonacept (interleukin-1 Trap) in patients with cryopyrin-associated periodic syndromes: results from two sequential placebo-controlled studies. Arthritis Rheum 2008; 58:2443-52.
77. Lachmann HJ, Kone-Paut I, Kuemmerle-Deschner JB etal. Use of canakinumab in the cryopyrin-associated periodic syndrome. N Engl J Med 2009; 360:2416-25.
78. Dowds TA, Masumoto J, Chen FF, Ogura Y, Inohara N, Nunez G. Regulation of cryopyrin/Pypaf1 signaling by pyrin, the familial Mediterranean fever gene product. Biochem Biophys Res Commun 2003; 302:575-80.
79. Papin S, Cuenin S, Agostini L etal. The SPRY domain of pyrin, mutated in familial Mediterranean fever patients, interacts with inflammasome components and inhibits proIL-1beta processing. Cell Death Differ 2007; 14:1457-66.
80. Chae JJ, Wood G, Masters SL etal. The B30.2 domain of pyrin, the familial Mediterranean fever protein, interacts directly with caspase-1 to modulate IL-1beta production. Proc Natl Acad Sci USA 2006; 103:9982-7.
81. Chae JJ, Komarow HD, Cheng J etal. Targeted disruption of pyrin, the FMF protein, causes heightened sensitivity to endotoxin and a defect in macrophage apoptosis. Mol Cell 2003; 11:591-604.
82. Yu JW, Fernandes-Alnemri T, Datta P etal. Pyrin activates the ASC pyroptosome in response to engagement by autoinflammatory PSTPIP1 mutants. Mol Cell 2007; 28:214-27.
83. Seshadri S, Duncan MD, Hart JM, Gavrilin MA, Wewers MD. Pyrin levels in human monocytes and monocyte-derived macrophages regulate IL-1beta processing and release. J Immunol 2007; 179:1274-81.
84. Gavrilin MA, Mitra S, Seshadri S etal. Pyrin critical to macrophage IL-1{beta} response to Francisella challenge. J Immunol 2009; 182:7982-9.
85. Chae JJ, Cho YH, Lee GS etal. Gain-of-function pyrin mutations induce NLRP3 protein-independent interleukin-1beta activation and severe autoinflammation in mice. Immunity 2011; 34:755-68.
86. Dinarello CA, Wolff SM, Goldfinger SE, Dale DC, Alling DW. Colchicine therapy for familial Mediterranean fever. A double-blind trial. N Engl J Med 1974; 291:934-7.
87. Hennig S, Bayegan K, Uffmann M, Thalhammer F, Winkler S. Pneumonia in a patient with familial Mediterranean fever successfully treated with anakinra-case report and review. Rheumatol Int 2010; doi: 10.1007/s00296-010-1429-y.